+3S

company

About

+3S specializes in the research, development, production and operation of antitoxin and antiserum biological products.

  • 101 - 250

Details

Last Funding Type
Post-IPO Equity
Last Funding Money Raised
¥50M
Industries
Biotechnology,Manufacturing,Medical,Pharmaceutical
Founded date
Nov 9, 1999
Number Of Employee
101 - 250
Operating Status
Active

Serum Biotech is a high-tech enterprise specialized in research, development, production, and sales of antitoxin and antiserum products in China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥50M
+3S has raised a total of ¥50M in funding over 2 rounds. Their latest funding was raised on Dec 27, 2016 from a Post-IPO Equity round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 27, 2016 Post-IPO Equity ¥50M 3 Detail

Investors

Number of Lead Investors
Number of Investors
3
+3S is funded by 3 investors. Tibet Jiuzheng Capital Investment and Optical Valley Venture Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Tibet Jiuzheng Capital Investment Post-IPO Equity
Optical Valley Venture Capital Post-IPO Equity
Ch-gemstone capital Post-IPO Equity